Stem Cells: An Answer to Treat Neurodegeneration?

B. Saurabh, havkar
{"title":"Stem Cells: An Answer to Treat Neurodegeneration?","authors":"B. Saurabh, havkar","doi":"10.4172/2168-975X.1000194","DOIUrl":null,"url":null,"abstract":"The demographic studies carried out in India reveal that approximately 10% of the population is over the age of 60. Statistics also reveal that by the year 2021, every seventh person will be a senior citizen. This pattern of ageing poses some serious health issues because with age comes age related disorders. The most pronounced amongst these are the neurodegenerative disorders, which are primarily characterized by neuronal loss /death in the brain or the spinal cord. In the brain, Alzheimer’s disease (AD) and Huntington’s disease (HD) result in loss of neurons, while specific and localized loss of dopaminergic neurons can be seen in Parkinson’s disease (PD). Loss and degeneration of motor neurons in the brainstem and spinal cord is a characteristic feature of Amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). In India, approximately 6 million people are living with these disorders. Though it is known that these disorders have neural pathologies, the exact mechanism behind neuronal loss is not yet clearly understood. As a result deciphering efficacious treatment methods for such disorders remains elusive. This lack of treatment methods poses a global burden on the society. Research is extensively carried out to target these diseases at a cellular level. Increasing attention over the past few years has been given to the treatment of neurodegenerative disorders by the use of stem cells. This review will focus mainly on current stem cell research carried out for neurodegenerative diseases, particularly in context to AD, PD, HD and ALS.","PeriodicalId":9146,"journal":{"name":"Brain disorders & therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain disorders & therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2168-975X.1000194","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The demographic studies carried out in India reveal that approximately 10% of the population is over the age of 60. Statistics also reveal that by the year 2021, every seventh person will be a senior citizen. This pattern of ageing poses some serious health issues because with age comes age related disorders. The most pronounced amongst these are the neurodegenerative disorders, which are primarily characterized by neuronal loss /death in the brain or the spinal cord. In the brain, Alzheimer’s disease (AD) and Huntington’s disease (HD) result in loss of neurons, while specific and localized loss of dopaminergic neurons can be seen in Parkinson’s disease (PD). Loss and degeneration of motor neurons in the brainstem and spinal cord is a characteristic feature of Amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). In India, approximately 6 million people are living with these disorders. Though it is known that these disorders have neural pathologies, the exact mechanism behind neuronal loss is not yet clearly understood. As a result deciphering efficacious treatment methods for such disorders remains elusive. This lack of treatment methods poses a global burden on the society. Research is extensively carried out to target these diseases at a cellular level. Increasing attention over the past few years has been given to the treatment of neurodegenerative disorders by the use of stem cells. This review will focus mainly on current stem cell research carried out for neurodegenerative diseases, particularly in context to AD, PD, HD and ALS.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
干细胞:治疗神经退行性疾病的答案?
在印度进行的人口研究显示,大约10%的人口年龄在60岁以上。统计数据还显示,到2021年,每七个人中就有一个是老年人。这种老龄化模式造成了一些严重的健康问题,因为随着年龄的增长,会出现与年龄有关的疾病。其中最明显的是神经退行性疾病,其主要特征是大脑或脊髓的神经元丧失/死亡。在大脑中,阿尔茨海默病(AD)和亨廷顿病(HD)导致神经元的损失,而在帕金森病(PD)中可以看到特异性和局部的多巴胺能神经元损失。脑干和脊髓运动神经元的丧失和退化是肌萎缩侧索硬化症(ALS)和脊髓性肌萎缩症(SMA)的一个特征。在印度,大约有600万人患有这些疾病。虽然已知这些疾病具有神经病理,但神经元丧失背后的确切机制尚不清楚。因此,破解这种疾病的有效治疗方法仍然难以捉摸。这种治疗方法的缺乏给社会带来了全球性的负担。在细胞水平上针对这些疾病进行了广泛的研究。在过去的几年里,越来越多的人注意到神经退行性疾病的治疗使用干细胞。本综述将主要关注目前干细胞在神经退行性疾病中的研究,特别是在AD、PD、HD和ALS方面的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
PTSD Treatment Literature: Old and Fresh Approaches Subjective of Brain Stem Why Should We Must Evaluate Cognitive Function in Hypertensive Patients Subjective of Brain Tumor Commentary of Mental Disorder
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1